Mission Statement, Vision, & Core Values of Teva Pharmaceutical Industries Limited (TEVA)

Have you ever wondered what drives a global pharmaceutical giant like Teva Pharmaceutical Industries? With a $16.544 billion revenue in 2024, how does Teva stay focused and aligned?

Understanding a company's mission, vision, and core values provides insight into its strategic objectives and operational culture. What are the guiding principles that shape Teva's actions and decisions in the ever-evolving healthcare landscape? Read on to discover the mission, vision, and core values that steer Teva Pharmaceutical Industries.

Teva Pharmaceutical Industries Limited (TEVA) An Overview of

Teva Pharmaceutical Industries Limited has a long history, starting in 1901 as a small wholesale drug business in Jerusalem. Over the years, it grew through a series of mergers and acquisitions to become a global pharmaceutical company. Today, Teva develops, produces, and markets a wide range of generic and specialty medicines, as well as biopharmaceutical products. These products aim to address various therapeutic areas, enhancing patient care worldwide. As of April 2025, Teva continues to be a major player in the pharmaceutical industry, driven by its commitment to innovation and health.

In 2024, Teva reported revenues of $16.1 billion. Key products driving this revenue include:

• AJOVY®: A preventative treatment for migraine, with revenue of $447 million.
• AUSTEDO®: A treatment for Huntington’s disease chorea and tardive dyskinesia, which generated $1.2 billion in revenue.
• COPAXONE®: A multiple sclerosis treatment, contributing $671 million in revenue.

Teva's growth is also notable in key markets, including North America and Europe, reflecting its global presence and the demand for its diverse product portfolio.

Teva Pharmaceutical Industries Limited stands as a leading company in the pharmaceutical sector due to its extensive portfolio of generic and specialty medicines, its global reach, and its commitment to research and development. To delve deeper into understanding what makes Teva a successful and influential player in the pharmaceutical industry, continue reading here: Exploring Teva Pharmaceutical Industries Limited (TEVA) Investor Profile: Who’s Buying and Why?

Teva Pharmaceutical Industries Limited (TEVA) Mission Statement

Teva Pharmaceutical Industries Limited's mission is to be a global leader in generics and biopharmaceuticals, improving the lives of patients around the globe. For more than a century, healthcare providers, patients, and caregivers have been using Teva's medicines.

Teva has a simple mission: improve the lives of patients by giving people around the world access to quality medicines.

The company serves approximately 200 million patients daily across 60 global markets, offering around 3,600 products.

Teva's mission is to be a global leader in generics and biopharmaceuticals, improving the lives of patients. It gives meaning to everything Teva does and it is the reason the company comes to work each morning. It is about Teva, the people of Teva, applying dedication, capabilities and skills, as well as passion and human touch, to make better health for millions of people worldwide. Teva's mission and values guide the company to ensure that patients, customers, colleagues and communities are at the heart of every decision Teva makes.

Key aspects of Teva's mission include:

• Improving patient health through innovative medicines and healthcare solutions.
• Developing affordable generic and specialty medicines.
• Providing access to critical healthcare treatments.

Teva is committed to providing high-quality, affordable generic pharmaceuticals and innovative medical solutions to improve global healthcare. The company recognizes its responsibility to invest in and support the communities it serves.

In 2024, Teva's revenues reached $16,544 million, marking a 4% increase (or 6% in local currency terms) compared to 2023. This growth was primarily driven by higher revenues from generic products across all segments and the introduction of lenalidomide capsules.

Teva's vision focuses on delivering innovative healthcare solutions with a commitment to improving patient outcomes globally. The company aims to be a leading pharmaceutical organization specialized in generic and specialty medicines.

Teva concentrates on critical therapeutic domains, including:

• Neuroscience
• Respiratory Diseases
• Oncology
• Pain Management

Teva is committed to conducting its business activities in a way that reflects the values of contribution to society, community, and the environment. Teva is steadfast in upholding the core values of leadership, excellence, creativity, and strategic discipline. In all Teva's activities and in Teva's business strategy, Teva is committed to supporting the interests of all stakeholders and in particular, Teva's broad range of customers.

Teva's commitment goes beyond producing high-quality generic medicines; the company also drives innovation in specialty and biopharmaceutical treatments by investing hundreds of millions of dollars annually in research and development. This dual focus allows Teva to enhance patient health by increasing access to essential medicines and staying at the forefront of pharmaceutical innovation.

Teva aspires to be an industry leader and an example of excellence in a constantly changing environment. The company is passionate about identifying new opportunities to support healthcare and believes that leadership happens with and through people.

Teva people are characterized by flexibility, self-assurance and determined to find the best solutions to all issues and opportunities. Teva's empowering working environment inspires people who are achievement-oriented, take initiative and are ready to embrace change and challenge. Teva owes these behaviors to a legacy of leadership which has created a unique Teva culture. Teva's culture, creative approach and long record of global success are what make Teva an industry leader. The way Teva operates brings out the best in Teva's people with continuous opportunities for personal growth alongside the Company's growth.

For healthcare professionals, patients, caregivers and families, Teva commits to push the boundaries to help deliver quality medicine wherever it is needed, discover life changing treatments and strive forward through scientific innovation. Because when it comes to health, good is not enough for Teva. This is the Teva legacy—to be stronger, bolder and simpler in the way the company operates and relentless in its growth by understanding what's next—in science, for patients, people and society.

Teva's core values guide the company's actions and decisions. Teva prioritizes caring, collaboration, and a commitment to excellence in everything it does.

Teva's core values include:

• Leading the way
• Focus and Accountability
• Getting it done together
• Innovating Where We Create Value
• Caring
• Making our families proud

These values express what Teva believes in, they represent the best in Teva, and they guide Teva in all it does.

Teva is focused on patients and the people who care for them. By integrating innovation, quality and accessibility, Teva's medicines are improving patient health.

Teva cares about the well-being of patients, caregivers, and the communities it touches. Teva cares about its colleagues; creating a respectful, diverse, and inclusive working environment.

In 2024, Teva invested $1.5 billion in Research and Development.

Teva improves health and contributes to people's well-being each and every day by acting with integrity and maintaining the highest standards of quality, ethics and compliance.

At Teva, the company believes in doing business the right way. Teva's corporate governance framework ensures transparency, accountability, and ethical business practices in all its operations. Teva prioritizes collaboration, integrity, and a commitment to excellence—principles that guide its actions and decisions daily.

Teva's extensive global network, with about 37,000 employees across 57 markets, ensures that Teva delivers medication reliably and efficiently. This commitment enables Teva to uphold the highest standards and consistently achieve its goal of better health for all, improving well-being and enhancing lives.

For additional insights into Teva's financial performance, you might find this blog post helpful: Breaking Down Teva Pharmaceutical Industries Limited (TEVA) Financial Health: Key Insights for Investors

Teva Pharmaceutical Industries Limited (TEVA) Vision Statement of

Teva Pharmaceutical Industries Limited operates with a mission to be a global leader in generics and biopharmaceuticals, improving patients' lives worldwide. This involves developing, producing, and marketing affordable medicines and innovative treatments. The company's financial performance reflects its commitment to this mission. In 2024, Teva reported revenues of $15.9 billion, with a significant portion attributed to its generics business, which constitutes about 56% of its revenue. This demonstrates the impact of providing affordable medicines globally. For further insights into Teva's background, explore Teva Pharmaceutical Industries Limited (TEVA): History, Ownership, Mission, How It Works & Makes Money.

Teva's strategic vision is centered around three core pillars: Generics, Innovative Medicines, and a focused portfolio. Each pillar contributes uniquely to the company's overall goals and is underpinned by specific strategies and financial allocations.

Generics: Providing Access to Affordable Medicines

Teva aims to maintain its leadership in the generics market by focusing on:

• Portfolio Optimization: Teva continually assesses and refines its generics portfolio to ensure alignment with market needs and profitability.
• Operational Efficiency: The company focuses on streamlining its manufacturing and supply chain processes to reduce costs and improve efficiency.
• Geographic Expansion: Teva strategically expands its presence in key markets to increase access to its generic medicines.

In 2024, Teva's generics business generated approximately $8.9 billion in revenue. The company's focus on operational efficiency and portfolio optimization has led to significant cost savings. For example, Teva's restructuring initiatives have targeted $3 billion in cost reductions by the end of 2024, enhancing the profitability of its generics segment.

Innovative Medicines: Developing Novel Treatments

Teva is dedicated to developing and bringing to market innovative medicines that address unmet medical needs. Key strategies include:

• Focus on Core Therapeutic Areas: Teva concentrates its research and development efforts on areas such as central nervous system (CNS) disorders, pain, and respiratory diseases.
• Strategic Partnerships: The company collaborates with other pharmaceutical companies and research institutions to accelerate the development of innovative treatments.
• Investment in R&D: Teva invests significantly in research and development to drive innovation and expand its pipeline of new medicines.

In 2024, Teva invested $1.2 billion in research and development, reflecting its commitment to innovation. Key innovative products, such as AUSTEDO for Huntington's disease and tardive dyskinesia, and Ajovy for migraine prevention, contributed significantly to the company's revenue. AUSTEDO, for instance, generated $1.25 billion in revenue in 2024, underscoring the impact of Teva's innovative medicines.

Focused Portfolio: Optimizing Resources for Growth

Teva is committed to maintaining a focused and sustainable portfolio by:

• Divesting Non-Core Assets: Teva divests assets that are not aligned with its strategic priorities to streamline operations and focus on core businesses.
• Prioritizing Key Products: The company focuses on promoting and expanding access to its key products, both generic and innovative.
• Managing Lifecycle: Teva actively manages the lifecycle of its products to maximize their value and ensure a continuous stream of revenue.

Teva's portfolio optimization efforts have included the divestiture of several non-core assets, generating additional capital to reinvest in strategic growth areas. The company's focus on key products and lifecycle management has helped sustain revenue and profitability, ensuring long-term value creation.

Teva Pharmaceutical Industries Limited (TEVA) Core Values of

While specific details on Teva Pharmaceutical Industries Limited's (TEVA) core values as of April 2025 are not available, we can infer key values based on their mission, vision, and recent activities. Teva's overarching aim is to improve people's health and enable them to live better lives. This commitment is reflected in several core principles that guide their operations and interactions with stakeholders. These inferred values emphasize patient well-being, innovation, integrity, and social responsibility.

Here are some potential core values, supported by examples of Teva's actions and initiatives:

Focus on Patients

Teva is dedicated to improving the lives of patients through access to essential medicines and innovative healthcare solutions. This commitment is evident in their:

• Wide Range of Products: Teva offers an extensive portfolio of generic and specialty medicines, addressing a variety of medical conditions and patient needs.
• Patient Support Programs: They provide various support programs to assist patients in managing their conditions and accessing their medications.
• Focus on Accessibility: Teva works to ensure that their medicines are affordable and accessible to patients worldwide.

Quality and Safety

Teva prioritizes the highest standards of quality and safety in the development, manufacturing, and distribution of its products. This dedication is demonstrated through:

• Stringent Manufacturing Processes: Teva adheres to strict quality control measures and complies with international regulatory standards in its manufacturing facilities.
• Pharmacovigilance: They actively monitor the safety and efficacy of their products to ensure patient well-being.
• Continuous Improvement: Teva continuously seeks to enhance its quality systems and processes to meet evolving industry standards.

Innovation and Excellence

Teva fosters a culture of innovation and strives for excellence in all aspects of its business. This is reflected in their:

• Investment in Research and Development: Teva invests significantly in R&D to develop new and improved medicines and healthcare solutions. In 2024, Teva's R&D expenditure was $1.2 billion, focusing on innovative treatments and drug delivery systems.
• Strategic Partnerships: They collaborate with other companies and research institutions to accelerate innovation and expand their product portfolio.
• Focus on Specialty Medicines: Teva is committed to developing and commercializing specialty medicines that address unmet medical needs.

Integrity and Ethics

Teva operates with the highest ethical standards and maintains transparency in its interactions with stakeholders. This commitment is evident in their:

• Code of Conduct: Teva has a comprehensive code of conduct that outlines ethical principles and guidelines for employees.
• Compliance Programs: They have robust compliance programs in place to ensure adherence to laws, regulations, and ethical standards.
• Transparency: Teva is committed to transparency in its business practices and communications.

Social Responsibility

Teva is committed to making a positive impact on society and contributing to the well-being of communities around the world. This is demonstrated through their:

• Environmental Sustainability Initiatives: Teva implements various initiatives to reduce its environmental footprint and promote sustainability.
• Philanthropic Activities: They support various charitable organizations and initiatives that address healthcare needs and promote community development.
• Access to Medicines Programs: Teva participates in programs to improve access to medicines in underserved communities.

For more insights into Teva's background, explore: Teva Pharmaceutical Industries Limited (TEVA): History, Ownership, Mission, How It Works & Makes Money